Goldman Sachs made a significant adjustment to its stance on Regenxbio Inc . (NASDAQ:RGNX), downgrading the stock from "Buy" to "Neutral" and reducing the price target dramatically to $14.00 from the ...

Goldman Sachs initiated coverage on Silence Therapeutics (NASDAQ:SLN), currently trading at $4.92 with a market cap of $232.3 million, with a Sell rating and a price target of $6.00. According to ...

Apple and Twilio are both in solid positions to benefit from the continued advancement of artificial intelligence. Click here ...

Fortinet, Inc. (NASDAQ:FTNT – Get Free Report)’s share price reached a new 52-week high on Tuesday after Susquehanna raised ...

Peloton Interactive, Inc. (NASDAQ:PTON – Get Free Report) shares were up 7.2% during mid-day trading on Monday after The ...

Wesfarmers Ltd (ASX: WES) shares have shot into the green this year, continuing their strong momentum from 2024.

The Canadian bank plans to exit its 10.1% interest in the brokerage firm, allowing it to shore up capital and strategically ...

Global power consumption in data centers will more than double by 2030 due to AI, analysts estimate. There will also be an ...

Even if tariffs ultimately aren’t imposed, the uncertainty and volatility caused by the threat of tariffs could prove costly.

GTEK's initial performance was poor, losing over 45% in its first year due to bearish investor sentiment. Read why I think ...

Even as Chinese investors rush into Chinese stocks, US stocks remain king amid the artificial intelligence race. Companies ...

The rise of artificial intelligence in finance has led many investors to question whether AI-powered tools like ChatGPT can ...